Circulating Tumors Cells and Circulating Endothelial Cells in Renal Cell Carcinoma

NCT01173445 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 19

Last updated 2011-10-20

No results posted yet for this study

Summary

The purpose of this study is to see if researchers can detect circulating tumor cells (CTC) and circulating endothelial cells (CEC) in the blood.

Conditions

Sponsors & Collaborators

  • University of Kansas

    lead OTHER

Principal Investigators

  • Peter J VanVeldhuizen, MD · University of Kansas Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2011-05-31
Completion
2011-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01173445 on ClinicalTrials.gov